中東及非洲創傷器材市場－產業趨勢及2030年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices Middle East And Africa Trauma Devices Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

中東及非洲創傷器材市場－產業趨勢及2030年預測

  • Medical Devices
  • Upcoming Report
  • Dec 2022
  • MEA
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Middle East And Africa Trauma Devices Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 13.66 Billion USD 26.24 Billion 2022 2030
Diagram Forecast Period
 2023 –2030
Diagram Market Size (Base Year)
 USD 13.66 Billion
Diagram Market Size (Forecast Year)
 USD 26.24 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

中東和非洲創傷器材市場，按產品（內固定器材、外固定器材和其他）、手術部位（下肢和上肢）、組織類型（硬組織和軟組織）、材料類型（不可吸收和生物可吸收）、患者年齡（成人和兒童）、最終用戶（醫院、創傷中心、門診手術中心和其他）、分銷管道（直接招標和零售）劃分預測行業和零售）。

中東和非洲創傷設備市場

中東和非洲創傷設備市場分析和規模

由於創傷器械在治療骨折、脫臼、扭傷和拉傷方面屢屢展現出卓越的療效，其市場價值正在不斷提升。目前，各種研究正在進行中，預計將為製造商在開發新型創新創傷器材方面提供競爭優勢，並在創傷器材市場創造各種其他機會。

Data Bridge Market Research 分析稱，2022 年創傷設備市場規模為 136.6 億美元，到 2030 年將飆升至 262.4 億美元，預計在 2022 年至 2030 年預測期內的複合年增長率為 8.50%。除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、通路分析、定價分析和監管框架。

創傷設備市場範圍和細分

報告指標

細節

預測期

2023年至2030年

基準年

2022

歷史歲月

2021（可自訂為 2015 - 2020 年）

定量單位

收入（十億美元）、銷售（單位）、定價（美元）

涵蓋的領域

產品（內固定器材、外固定器材及其他）、手術部位（下肢和上肢）、組織類型（硬組織和軟組織）、材料類型（不可吸收和生物可吸收）、病人年齡（成人和兒童）、最終用戶（醫院、創傷中心、門診手術中心及其他）、通路（直接投標和零售）

覆蓋國家

沙烏地阿拉伯、阿聯酋、南非、埃及、以色列、中東和非洲 (MEA) 其他地區（作為中東和非洲 (MEA) 的一部分）

涵蓋的市場參與者

上海凱利泰克醫療器材有限公司（中國）、威高集團（中國）、微創醫療科學有限公司（中國）、Orthofix US LLC（美國）、CONMED Corporation（美國）、Wright Medical Group NV（美國）、NuVasive, Inc（美國）、Corin Group（美國）、Enovis（美國）、OsteoMed（美國）、Invibio Ltd.（美國）、gpcmedical.com（美國）、美敦力（愛爾蘭）、施樂輝（美國）、Integra LifeSciences（美國）、B. Braun SE（德國）、史賽克（美國）

市場機會
  • 政府更加重視新藥研發

市場定義

創傷器械是用於創傷照護的臨床工具。外在因素引起的創傷包括骨折、脫臼、扭傷、拉傷和燒傷。這些工具在涉及長骨（例如骨折）的病例中尤其有用。創傷器材還包括上肢和下肢部位，例如膝蓋、關節、腿部、脊椎等。

創傷器材市場動態

驅動程式

  • 全球老年人口急劇增加

主要驅動因素是交通事故的增加。預計老年人因事故和跌倒導致嚴重骨折的人數將會增加，需要使用骨折固定器，這將推動市場成長。

  • 老齡人口增加

人口老化導致骨關節炎骨折風險增加，骨質疏鬆症盛行率上升，以及骨科生物製品和可生物降解材料等技術進步，都將推動市場發展。此外，交通事故、運動傷害發生率上升以及人們生活方式的改變也將推動該產業的發展。

  •  創傷造成的損傷

創傷包括骨折或骨斷裂以及組織損傷。這些損傷可以透過創傷器械進行治療，這些器械可以取代受損的身體部位。機動車事故造成了大量創傷。新興國家事故發生頻率的上升推動了市場的發展。

機會

  • 政府更重視新藥的發現與開發

推動市場收入成長的最重要因素包括：COVID-19 在全球的快速蔓延、患者群體的快速擴大、COVID-19 疫情期間醫療保健解決方案供需的顯著變化、遠距醫療和遠距醫療趨勢的興起，以及對先進即時診斷的需求日益增長。政府增加對 COVID-19 疫苗研發的資助，政府更加重視新藥研發，以及政府更加重視改善醫療保健供應鏈體系，所有這些都有助於推動市場收入的成長。

限制/挑戰

  • 創傷器械成本高昂

創傷器材的高成本、內固定器材相關的過敏、感染風險、價格波動以及經驗豐富的專家的匱乏，預計將阻礙市場擴張。此外，由於患者相容性和過敏問題，政府部門不會迅速批准用於製造創傷器械的材料。這些植入物的材料需要具有生物相容性和高度惰性。因此，企業很難獲得這些器械的批准。

本創傷器材市場報告詳細介紹了最新發展動態、貿易法規、進出口分析、生產分析、價值鏈優化、市場份額、國內和本地市場參與者的影響，並分析了新興收入來源、市場法規變化、戰略市場增長分析、市場規模、品類市場增長、應用領域和市場主導地位、產品審批、產品發布、地域擴張以及市場技術創新等方面的機遇。如需了解更多關於創傷器材市場的信息，請聯繫 Data Bridge 市場研究部門以獲取分析師簡報，我們的團隊將協助您做出明智的市場決策，實現市場成長。

COVID-19對創傷設備市場的影響

新冠疫情對全球經濟造成了重大衝擊，所有產業在2020年都經歷了大幅下滑。疫情給醫療機構帶來了巨大的壓力，使其難以控制疾病傳播，業界也遭受了重創。由於創傷固定手術並非必需，疫情期間許多治療和外科手術被暫停或永久推遲。疫情爆發後的最初幾個月，創傷固定器材的需求低迷，限制了產業的成長。此外，多專科醫院的擴張，尤其是在印度等新興市場，將為創傷患者提供更完善的治療方案，這將增加產業收入。同樣，各政府機構提供的低成本治療方案，也將成為低收入國家市場擴張的重要刺激因素。

最新動態

  • 2019年，科爾法克斯公司收購了私募股權公司DJO Global, Inc，該公司旗下擁有多個部門，包括支撐和支架、外科、足部護理、醫療保健解決方案、復健和消費者業務。此次收購將有助於公司增加收入，從而獲得更多利潤。
  • 2019年，美敦力收購了Titan Spine公司。此次收購擴大了美敦力的鈦質脊椎椎間植入物和表面技術產品組合。這也增強了該公司創傷器械的供應能力。

中東和非洲創傷設備市場範圍

創傷器械市場根據類型、手術部位和最終用戶進行細分。這些細分市場的成長將有助於您分析行業中成長乏力的細分市場，並為用戶提供有價值的市場概覽和市場洞察，幫助他們做出策略決策，確定核心市場應用。

類型

  • 內固定器
  • 鋼板和螺絲
  • 桿和銷
  • 其他的
  • 外固定器
  • 單平面和雙平面固定器
  • 環形固定器
  • 混合固定器

手術部位

  • 上肢
  • 手和腕部
  • 肩膀
  • 手臂
  • 彎頭
  • 下肢
  • 髖部和骨盆
  • 小腿
  • 足部和踝部
  • 膝蓋
  • 大腿

終端用戶

創傷設備市場區域分析/洞察

對創傷設備市場進行了分析，並按國家、類型、手術部位和最終用戶提供了市場規模洞察和趨勢，如上所述。

創傷設備市場報告涵蓋的國家包括沙烏地阿拉伯、阿聯酋、南非、埃及、以色列、中東和非洲（MEA）其他地區。

沙烏地阿拉伯憑藉其眾多公司、研發能力以及微創手術的日益普及，在中東和非洲創傷設備市場佔據主導地位。

報告的國家部分還提供了各個市場的影響因素以及國內市場監管變化，這些變化會影響市場的當前和未來趨勢。下游和上游價值鏈分析、技術趨勢、波特五力模型分析以及案例研究等數據點是預測各國市場狀況的一些指標。此外，在對國家/地區數據進行預測分析時，還考慮了全球品牌的存在和可用性，以及它們因本土和國內品牌的激烈競爭或稀缺而面臨的挑戰，國內關稅和貿易路線的影響。   

醫療保健基礎設施成長安裝基礎和新技術滲透

創傷器材市場也為您提供詳細的市場分析，涵蓋各國資本設備醫療支出的成長、創傷器材市場各類產品的安裝基數、生命線曲線技術的影響以及醫療監管環境的變化及其對創傷器材市場的影響。數據涵蓋2011年至2021年的歷史時期。

競爭格局與創傷設備市場佔有率分析

創傷器材市場競爭格局提供了按競爭對手劃分的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、全球佈局、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據僅與公司在創傷器材市場的重點相關。

創傷設備市場的一些主要參與者包括：

  • 上海凱利泰克醫療科技有限公司 (中國)
  • 威高集團（中國）
  • 微創醫療科學股份有限公司（中國）
  • Orthofix US LLC（美國）
  • CONMED公司（美國）
  • Wright Medical Group NV（美國）
  • NuVasive, Inc（美國）
  • Corin集團（美國）
  • Enovis（美國）
  • OsteoMed（美國）
  • Invibio Ltd.（美國）
  • gpcmedical.com（美國）
  • 美敦力（愛爾蘭）
  • 施樂輝（美國）
  • Integra LifeSciences（美國）
  • B. Braun SE（德國）
  • 史賽克（美國）

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

 

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 COST ANALYSIS BREAKDOWN

8 TECHNONLOGY ROADMAP

9 INNOVATION TRACKER AND STRATEGIC ANALYSIS

9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

9.1.1 JOINT VENTURES

9.1.2 MERGERS AND ACQUISITIONS

9.1.3 LICENSING AND PARTNERSHIP

9.1.4 TECHNOLOGY COLLABORATIONS

9.1.5 STRATEGIC DIVESTMENTS

9.2 NUMBER OF PRODUCTS IN DEVELOPMENT

9.3 STAGE OF DEVELOPMENT

9.4 TIMELINES AND MILESTONES

9.5 INNOVATION STRATEGIES AND METHODOLOGIES

9.6 RISK ASSESSMENT AND MITIGATION

9.7 FUTURE OUTLOOK

10 REGULATORY COMPLIANCE

10.1 REGULATORY AUTHORITIES

10.2 REGULATORY CLASSIFICATIONS

10.3 REGULATORY SUBMISSIONS

10.4 INTERNATIONAL HARMONIZATION

10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

10.6 REGULATORY CHALLENGES AND STRATEGIES

11 REIMBURSEMENT FRAMEWORK

12 VALUE CHAIN ANALYSIS

13 HEALTHCARE ECONOMY

13.1 HEALTHCARE EXPENDITURE

13.2 CAPITAL EXPENDITURE

13.3 CAPEX TRENDS

13.4 CAPEX ALLOCATION

13.5 FUNDING SOURCES

13.6 INDUSTRY BENCHMARKS

13.7 GDP RATION IN OVERALL GDP

13.8 HEALTHCARE SYSTEM STRUCTURE

13.9 GOVERNMENT POLICIES

13.1 ECONOMIC DEVELOPMENT

14 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)

14.2 CORE TRAUMA DEVICES

14.2.1 INTERNAL FIXATOR DEVICES

14.2.1.1. SCREW

14.2.1.1.1. BY TYPE

14.2.1.1.1.1 COMPRESSION BONE SCREWS

14.2.1.1.1.1.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.1.2. MARKET VOLUME (UNITS)

14.2.1.1.1.1.3. AVERAGE SELLING PRICE (USD)

14.2.1.1.1.2 ARTHRODESIS SCREWS

14.2.1.1.1.2.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.2.2. MARKET VOLUME (UNITS)

14.2.1.1.1.2.3. AVERAGE SELLING PRICE (USD)

14.2.1.1.1.3 BONE SCREW WASHERS

14.2.1.1.1.3.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.3.2. MARKET VOLUME (UNITS)

14.2.1.1.1.3.3. AVERAGE SELLING PRICE (USD)

 

14.2.1.1.2. BY LENGTH

14.2.1.1.2.1 1.5 MM

14.2.1.1.2.2 2 MM

14.2.1.1.2.3 2.7 MM

14.2.1.1.2.4 3.5 MM

14.2.1.1.2.5 OTHERS

14.2.1.1.3. BY MATERIAL

14.2.1.1.3.1 BIOABSORBABLE SCREWS

14.2.1.1.3.2 NON- BIOABSORBABLE SCREWS

14.2.1.1.4. OTHERS

14.2.1.2. NAILING

14.2.1.2.1. TIBIA NAILING SYSTEM

14.2.1.2.1.1 MARKET VALUE (USD MILLION)

14.2.1.2.1.2 MARKET VOLUME (UNITS)

14.2.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.2.1.2.2. FEMUR NAILING SYSTEM

14.2.1.2.2.1 MARKET VALUE (USD MILLION)

14.2.1.2.2.2 MARKET VOLUME (UNITS)

14.2.1.2.2.3 AVERAGE SELLING PRICE (USD)

14.2.1.2.3. OTHERS

14.2.1.2.3.1 MARKET VALUE (USD MILLION)

14.2.1.2.3.2 MARKET VOLUME (UNITS)

14.2.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.2.1.3. PLATES

14.2.1.3.1. COMPRESSION PLATES

14.2.1.3.1.1 MARKET VALUE (USD MILLION)

14.2.1.3.1.2 MARKET VOLUME (UNITS)

14.2.1.3.1.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.2. OSTEOTOMY PLATES

14.2.1.3.2.1 MARKET VALUE (USD MILLION)

14.2.1.3.2.2 MARKET VOLUME (UNITS)

14.2.1.3.2.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.3. ARTHRODESIS PLATES

14.2.1.3.3.1 MARKET VALUE (USD MILLION)

14.2.1.3.3.2 MARKET VOLUME (UNITS)

14.2.1.3.3.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.4. OTHERS

 

14.2.1.4. STAPLES

14.2.1.4.1. MARKET VALUE (USD MILLION)

14.2.1.4.2. MARKET VOLUME (UNITS)

14.2.1.4.3. AVERAGE SELLING PRICE (USD)

14.2.1.5. WIRES

14.2.1.5.1. MARKET VALUE (USD MILLION)

14.2.1.5.2. MARKET VOLUME (UNITS)

14.2.1.5.3. AVERAGE SELLING PRICE (USD)

14.2.1.6. RODS & PINS

14.2.1.6.1. MARKET VALUE (USD MILLION)

14.2.1.6.2. MARKET VOLUME (UNITS)

14.2.1.6.3. AVERAGE SELLING PRICE (USD)

14.2.1.7. OTHERS

14.2.2 EXTERNAL FIXATOR DEVICES

14.2.2.1. UNILATERAL & BILATERAL EXTERNAL FIXATORS

14.2.2.1.1. MARKET VALUE (USD MILLION)

14.2.2.1.2. MARKET VOLUME (UNITS)

14.2.2.1.3. AVERAGE SELLING PRICE (USD)

14.2.2.2. CIRCULAR FIXATORS

14.2.2.2.1. MARKET VALUE (USD MILLION)

14.2.2.2.2. MARKET VOLUME (UNITS)

14.2.2.2.3. AVERAGE SELLING PRICE (USD)

14.2.2.3. HYBRID FIXATORS

14.2.2.3.1. MARKET VALUE (USD MILLION)

14.2.2.3.2. MARKET VOLUME (UNITS)

14.2.2.3.3. AVERAGE SELLING PRICE (USD)

14.2.2.3.4. OTHERS

14.2.3 INTRAOSSEOUS DEVICES

14.2.3.1. MANUAL

14.2.3.1.1. MARKET VALUE (USD MILLION)

14.2.3.1.2. MARKET VOLUME (UNITS)

14.2.3.1.3. AVERAGE SELLING PRICE (USD)

14.2.3.2. SEMI-AUTOMATED

14.2.3.2.1. MARKET VALUE (USD MILLION)

14.2.3.2.2. MARKET VOLUME (UNITS)

14.2.3.2.3. AVERAGE SELLING PRICE (USD)

14.2.3.3. AUTOMATED

14.2.3.3.1. MARKET VALUE (USD MILLION)

14.2.3.3.2. MARKET VOLUME (UNITS)

14.2.3.3.3. AVERAGE SELLING PRICE (USD)

14.3 SHOULDER ARTHROPLASTY DEVICES

14.3.1 BY TYPE

14.3.1.1. SHOULDER ARTHROPLASTY RESURFACING IMPLANTS

14.3.1.1.1. RESURFACING HEAD

14.3.1.1.1.1 MARKET VALUE (USD MILLION)

14.3.1.1.1.2 MARKET VOLUME (UNITS)

14.3.1.1.1.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.2. SHOULDER CUP

14.3.1.1.2.1 MARKET VALUE (USD MILLION)

14.3.1.1.2.2 MARKET VOLUME (UNITS)

14.3.1.1.2.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.3. HUMERAL STEM

14.3.1.1.3.1 MARKET VALUE (USD MILLION)

14.3.1.1.3.2 MARKET VOLUME (UNITS)

14.3.1.1.3.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.4. ECCENTER

14.3.1.1.4.1 MARKET VALUE (USD MILLION)

14.3.1.1.4.2 MARKET VOLUME (UNITS)

14.3.1.1.4.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.5. GLENOID

14.3.1.1.5.1 MARKET VALUE (USD MILLION)

14.3.1.1.5.2 MARKET VOLUME (UNITS)

14.3.1.1.5.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.6. SHELL SCREWS

14.3.1.1.6.1 MARKET VALUE (USD MILLION)

14.3.1.1.6.2 MARKET VOLUME (UNITS)

14.3.1.1.6.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.7. OTHER

14.3.1.2. SHOULDER ARTHROPLASTY TRAUMA DEVICES

14.3.1.2.1. STEM INSTRUMENTS

14.3.1.2.1.1 MARKET VALUE (USD MILLION)

14.3.1.2.1.2 MARKET VOLUME (UNITS)

14.3.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.3.1.2.2. PRESS INSTRUMENTS

14.3.1.2.2.1 MARKET VALUE (USD MILLION)

14.3.1.2.2.2 MARKET VOLUME (UNITS)

14.3.1.2.2.3 AVERAGE SELLING PRICE (USD)

 

14.3.1.2.3. GLENOID INSERTION INSTRUMENTS

14.3.1.2.3.1 MARKET VALUE (USD MILLION)

14.3.1.2.3.2 MARKET VOLUME (UNITS)

14.3.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.3.1.2.4. OTHER

14.3.1.3. SHOULDER ARTHROPLASTY PLATFORM SYSTEMS

14.3.2 BY PROCEDURE

14.3.2.1. PARTIAL SHOULDER ARTHROPLASTY

14.3.2.1.1. PARTIAL RESURFACING

14.3.2.1.2. HEMI RESURFACING

14.3.2.1.3. PARTIAL-MID HEAD

14.3.2.1.4. STEMMED HEMI

14.3.2.2. TOTAL SHOULDER ARTHROPLASTY

14.3.2.2.1. TOTAL-MID HEAD

14.3.2.2.2. TOTAL CONVENTIONAL

14.3.2.2.3. TOTAL REVERSE

14.3.2.3. REVIION SHOULDER ARTHROPLASTY

14.4 FOOT AND ANKLE ARTHROPLASTY DEVICES

14.4.1 INTERANL FIXATION DEVICES

14.4.1.1. PLATES

14.4.1.1.1. MARKET VALUE (USD MILLION)

14.4.1.1.2. MARKET VOLUME (UNITS)

14.4.1.1.3. AVERAGE SELLING PRICE (USD)

14.4.1.2. SCREW

14.4.1.2.1. MARKET VALUE (USD MILLION)

14.4.1.2.2. MARKET VOLUME (UNITS)

14.4.1.2.3. AVERAGE SELLING PRICE (USD)

14.4.1.3. FUSION NAILS

14.4.1.3.1. MARKET VALUE (USD MILLION)

14.4.1.3.2. MARKET VOLUME (UNITS)

14.4.1.3.3. AVERAGE SELLING PRICE (USD)

14.4.1.4. WIRE & PINS

14.4.1.4.1. MARKET VALUE (USD MILLION)

14.4.1.4.2. MARKET VOLUME (UNITS)

14.4.1.4.3. AVERAGE SELLING PRICE (USD)

14.4.1.5. INTRAMEDULLARY IMPLANT

14.4.1.5.1. MARKET VALUE (USD MILLION)

14.4.1.5.2. MARKET VOLUME (UNITS)

14.4.1.5.3. AVERAGE SELLING PRICE (USD)

 

14.4.1.6. HAMMERTOE FIXATION SYSTEM

14.4.1.6.1. MARKET VALUE (USD MILLION)

14.4.1.6.2. MARKET VOLUME (UNITS)

14.4.1.6.3. AVERAGE SELLING PRICE (USD)

14.4.1.7. STAPLE FIXATION SYSTEM

14.4.1.7.1. MARKET VALUE (USD MILLION)

14.4.1.7.2. MARKET VOLUME (UNITS)

14.4.1.7.3. AVERAGE SELLING PRICE (USD)

14.4.1.8. OTHER

14.4.2 EXTERNAL FIXATION DEVICES

14.4.2.1. RING ANKLE FIXATORS

14.4.2.1.1. MARKET VALUE (USD MILLION)

14.4.2.1.2. MARKET VOLUME (UNITS)

14.4.2.1.3. AVERAGE SELLING PRICE (USD)

14.4.2.2. UNILATERAL FIXATORS

14.4.2.2.1. MARKET VALUE (USD MILLION)

14.4.2.2.2. MARKET VOLUME (UNITS)

14.4.2.2.3. AVERAGE SELLING PRICE (USD)

14.4.2.3. HYBRID FIXATORS

14.4.2.3.1. MARKET VALUE (USD MILLION)

14.4.2.3.2. MARKET VOLUME (UNITS)

14.4.2.3.3. AVERAGE SELLING PRICE (USD)

14.4.2.4. OTEHR

14.4.3 JOINT IMPLANT

14.4.3.1. ANKLE IMPLANT

14.4.3.1.1. MARKET VALUE (USD MILLION)

14.4.3.1.2. MARKET VOLUME (UNITS)

14.4.3.1.3. AVERAGE SELLING PRICE (USD)

14.4.3.2. SUBTALAR JOINT IMPLANT

14.4.3.2.1. MARKET VALUE (USD MILLION)

14.4.3.2.2. MARKET VOLUME (UNITS)

14.4.3.2.3. AVERAGE SELLING PRICE (USD)

14.4.3.3. PHALANGEAL IMPLANTS

14.4.3.3.1. MARKET VALUE (USD MILLION)

14.4.3.3.2. MARKET VOLUME (UNITS)

14.4.3.3.3. AVERAGE SELLING PRICE (USD)

14.4.3.4. OTHER

 

14.4.4 PROSTHESES

14.4.4.1. SOLID ANKLE CUSHION HEEL PROSTHESES

14.4.4.1.1. MARKET VALUE (USD MILLION)

14.4.4.1.2. MARKET VOLUME (UNITS)

14.4.4.1.3. AVERAGE SELLING PRICE (USD)

14.4.4.2. SINGLE ANKLE PROSTHESES

14.4.4.2.1. MARKET VALUE (USD MILLION)

14.4.4.2.2. MARKET VOLUME (UNITS)

14.4.4.2.3. AVERAGE SELLING PRICE (USD)

14.4.4.3. MULTIAXIAL PROSTHESES

14.4.4.3.1. MARKET VALUE (USD MILLION)

14.4.4.3.2. MARKET VOLUME (UNITS)

14.4.4.3.3. AVERAGE SELLING PRICE (USD)

14.4.4.4. DYNAMIC RESPONSE ENERGY STORING PROSTHESES

14.4.4.4.1. MARKET VALUE (USD MILLION)

14.4.4.4.2. MARKET VOLUME (UNITS)

14.4.4.4.3. AVERAGE SELLING PRICE (USD)

14.4.4.5. MICROPROCESSOR CONTROLLED PROSTHESES

14.5 BIOLOGICS

14.5.1 BONE GRFTS

14.5.1.1. ALLOGRAFT

14.5.1.1.1. DEMINERALIZED BONE MATRIX

14.5.1.1.1.1 MARKET VALUE (USD MILLION)

14.5.1.1.1.2 MARKET VOLUME (UNITS)

14.5.1.1.1.3 AVERAGE SELLING PRICE (USD)

14.5.1.1.2. VIABLE BONE MATRIX

14.5.1.1.2.1 MARKET VALUE (USD MILLION)

14.5.1.1.2.2 MARKET VOLUME (UNITS)

14.5.1.1.2.3 AVERAGE SELLING PRICE (USD)

14.5.1.1.3. OTHER

14.5.1.2. SYNTHETIC

14.5.1.2.1. CERAMICS

14.5.1.2.1.1 HAP

14.5.1.2.1.1.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.1.2. MARKET VOLUME (UNITS)

14.5.1.2.1.1.3. AVERAGE SELLING PRICE (USD)

 

14.5.1.2.1.2 Β-TCP

14.5.1.2.1.2.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.2.2. MARKET VOLUME (UNITS)

14.5.1.2.1.2.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.3 Α-TCP

14.5.1.2.1.3.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.3.2. MARKET VOLUME (UNITS)

14.5.1.2.1.3.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.4 BI-PHASIC CALCIUM PHOSPHATES (BCP)

14.5.1.2.1.4.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.4.2. MARKET VOLUME (UNITS)

14.5.1.2.1.4.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.5 OTHERS

14.5.1.2.2. COMPOSITES

14.5.1.2.2.1 MARKET VALUE (USD MILLION)

14.5.1.2.2.2 MARKET VOLUME (UNITS)

14.5.1.2.2.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.3. POLYMERS

14.5.1.2.3.1 MARKET VALUE (USD MILLION)

14.5.1.2.3.2 MARKET VOLUME (UNITS)

14.5.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.4. BONE MORPHOGENIC PROTEINS (BMP)

14.5.1.2.4.1 MARKET VALUE (USD MILLION)

14.5.1.2.4.2 MARKET VOLUME (UNITS)

14.5.1.2.4.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.5. OTHER

14.5.2 ACELLULAR DERMAL MATRIX

14.5.2.1. MARKET VALUE (USD MILLION)

14.5.2.2. MARKET VOLUME (UNITS)

14.5.2.3. AVERAGE SELLING PRICE (USD)

 

14.5.3 ALLOGRAFT BONE WEDGE

14.5.3.1. UNICORTAL

14.5.3.1.1. MARKET VALUE (USD MILLION)

14.5.3.1.2. MARKET VOLUME (UNITS)

14.5.3.1.3. AVERAGE SELLING PRICE (USD)

14.5.3.2. TRICORTAL

14.5.3.2.1. MARKET VALUE (USD MILLION)

14.5.3.2.2. MARKET VOLUME (UNITS)

14.5.3.2.3. AVERAGE SELLING PRICE (USD)

14.5.4 NERVE CONDUIT & WRAPS

14.5.4.1. MARKET VALUE (USD MILLION)

14.5.4.2. MARKET VOLUME (UNITS)

14.5.4.3. AVERAGE SELLING PRICE (USD)

14.5.5 SHAFT

14.5.5.1. MARKET VALUE (USD MILLION)

14.5.5.2. MARKET VOLUME (UNITS)

14.5.5.3. AVERAGE SELLING PRICE (USD)

14.5.6 CHIPS

14.5.6.1. MARKET VALUE (USD MILLION)

14.5.6.2. MARKET VOLUME (UNITS)

14.5.6.3. AVERAGE SELLING PRICE (USD)

14.5.7 OTHER

14.6 OTHER

14.6.1 BONE ADHESIVES

14.6.1.1. BONE CEMENT

14.6.1.1.1. BY TYPE

14.6.1.1.1.1 POLYMETHYL METHACRYLATE (PMMA) CEMENT

14.6.1.1.1.1.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.1.2. MARKET VOLUME (UNITS)

14.6.1.1.1.1.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.2 CALCIUM PHOSPHATE CEMENT (CPC)

14.6.1.1.1.2.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.2.2. MARKET VOLUME (UNITS)

14.6.1.1.1.2.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.3 GLASS POLYALKENOATE CEMENT (GPC)

14.6.1.1.1.3.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.3.2. MARKET VOLUME (UNITS)

14.6.1.1.1.3.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.4 OTHERS

14.6.1.1.2. BY LOADING

14.6.1.1.2.1 ANTIBIOTIC-LOADED BONE CEMENT

14.6.1.1.2.2 NON-ANTIBIOTIC-LOADED BONE CEMENT

14.6.1.2. BONE GLUE

14.6.1.2.1. NATURAL BONE GLUE

14.6.1.2.1.1 MARKET VALUE (USD MILLION)

14.6.1.2.1.2 MARKET VOLUME (UNITS)

14.6.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.6.1.2.2. SYNTHETIC BONE GLUE

14.6.1.2.2.1 MARKET VALUE (USD MILLION)

14.6.1.2.2.2 MARKET VOLUME (UNITS)

14.6.1.2.2.3 AVERAGE SELLING PRICE (USD)

15 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY MATERIAL

15.1 OVERVIEW

15.2 BIO-ABSORBABLE

15.2.1 OLYLACTIC ACID POLYMER

15.2.2 POLYGLYCOLIC ACID POLYMERS

15.2.3 OTHERS

15.3 NON- ABSORBABLE

15.3.1 TITANIUM

15.3.2 STAINLESS STEEL

15.3.3 OTHERS

16 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY SURGICAL SITE

16.1 OVERVIEW

16.2 UPPER EXTRIMITIES

16.2.1 SHOULDER

16.2.2 HAND AND WRIST

16.2.3 MAXILLOFACIAL

16.2.4 ELBOW

16.2.5 ARM

16.2.6 OTHERS

16.3 LOWER EXTREMETIES

16.3.1 HIP

16.3.2 THIGH

16.3.3 KNEE

16.3.4 LEG

16.3.5 ANKLE

16.3.6 FOOT

16.3.7 OTHERS

17 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY TRAUMA TYPE

17.1 OVERVIEW

17.2 DISLOCATIONS

17.3 JOINT REPLACEMENT AND FRACTURES

17.4 NERVE DISEASES AND SOFT TISSUE INJURIES

17.5 OTHERS

18 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY PATIENT TYPE

18.1 OVERVIEW

18.2 PEDIATRIC

18.2.1 MALE

18.2.2 FEMALE

18.3 ADULT

18.3.1 MALE

18.3.2 FEMALE

18.4 GERIATRIC

18.4.1 MALE

18.4.2 FEMALE

19 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY END USER

19.1 OVERVIEW

19.2 HOSPITALS

19.2.1 BY TYPE

19.2.1.1. PUBLIC

19.2.1.2. PRIVATE

 

19.2.2 BY TIER

19.2.2.1. TIER 1

19.2.2.2. TIER 2

19.2.2.3. TIER 3

19.3 TRAUMA CENTRES

19.4 AMBULATORY SURGICAL CENTRES

19.5 SPECIALITY CLINICS

19.6 OTHER

20 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY DISTRIBUTION CHANNEL

20.1 OVERVIEW

20.2 DIRECT TENDERS

20.3 RETAIL SALES

20.3.1 ONLINE SALES

20.3.2 OFFLINE SALES

20.4 OTHERS

21 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, SWOT AND DBMR ANALYSIS

22 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY LANDSCAPE

22.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)

22.2 MERGERS & ACQUISITIONS

22.3 NEW PRODUCT DEVELOPMENT & APPROVALS

22.4 EXPANSIONS

22.5 REGULATORY CHANGES

22.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

23 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY REGION

MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

23.1 MIDDLE EAST AND AFRICA

23.1.1 SOUTH AFRICA

23.1.2 EGYPT

23.1.3 BAHRAIN

23.1.4 UNITED ARAB EMIRATES

23.1.5 KUWAIT

23.1.6 OMAN

23.1.7 QATAR

23.1.8 SAUDI ARABIA

23.1.9 REST OF MEA

23.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

24 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY PROFILE

24.1 GLOBAL COMPANIES

24.1.1 STRYKER

24.1.1.1. COMPANY OVERVIEW

24.1.1.2. REVENUE ANALYSIS

24.1.1.3. GEOGRAPHIC PRESENCE

24.1.1.4. PRODUCT PORTFOLIO

24.1.1.5. RECENT DEVELOPMENTS

24.1.2 DEPUY SYNTHES(JOHNSON & JOHNSON)

24.1.2.1. COMPANY OVERVIEW

24.1.2.2. REVENUE ANALYSIS

24.1.2.3. GEOGRAPHIC PRESENCE

24.1.2.4. PRODUCT PORTFOLIO

24.1.2.5. RECENT DEVELOPMENTS

24.1.3 ZIMMER BIOMET

24.1.3.1. COMPANY OVERVIEW

24.1.3.2. REVENUE ANALYSIS

24.1.3.3. GEOGRAPHIC PRESENCE

24.1.3.4. PRODUCT PORTFOLIO

24.1.3.5. RECENT DEVELOPMENTS

24.1.4 MEDTRONICS

24.1.4.1. COMPANY OVERVIEW

24.1.4.2. REVENUE ANALYSIS

24.1.4.3. GEOGRAPHIC PRESENCE

24.1.4.4. PRODUCT PORTFOLIO

24.1.4.5. RECENT DEVELOPMENTS

24.1.5 ARTHREX, INC

24.1.5.1. COMPANY OVERVIEW

24.1.5.2. REVENUE ANALYSIS

24.1.5.3. GEOGRAPHIC PRESENCE

24.1.5.4. PRODUCT PORTFOLIO

24.1.5.5. RECENT DEVELOPMENTS

 

24.1.6 SMITH+NEPHEW

24.1.6.1. COMPANY OVERVIEW

24.1.6.2. REVENUE ANALYSIS

24.1.6.3. GEOGRAPHIC PRESENCE

24.1.6.4. PRODUCT PORTFOLIO

24.1.6.5. RECENT DEVELOPMENTS

24.1.7 GLOBUS MEDICAL

24.1.7.1. COMPANY OVERVIEW

24.1.7.2. REVENUE ANALYSIS

24.1.7.3. GEOGRAPHIC PRESENCE

24.1.7.4. PRODUCT PORTFOLIO

24.1.7.5. RECENT DEVELOPMENTS

24.1.8 ORTHOMED

24.1.8.1. COMPANY OVERVIEW

24.1.8.2. REVENUE ANALYSIS

24.1.8.3. GEOGRAPHIC PRESENCE

24.1.8.4. PRODUCT PORTFOLIO

24.1.8.5. RECENT DEVELOPMENTS

24.1.9 DJO, LLC

24.1.9.1. COMPANY OVERVIEW

24.1.9.2. REVENUE ANALYSIS

24.1.9.3. GEOGRAPHIC PRESENCE

24.1.9.4. PRODUCT PORTFOLIO

24.1.9.5. RECENT DEVELOPMENTS

24.1.10 B. BRAUN SE

24.1.10.1. COMPANY OVERVIEW

24.1.10.2. REVENUE ANALYSIS

24.1.10.3. GEOGRAPHIC PRESENCE

24.1.10.4. PRODUCT PORTFOLIO

24.1.10.5. RECENT DEVELOPMENTS

24.1.11 ZIMED MEDIKAL

24.1.11.1. COMPANY OVERVIEW

24.1.11.2. REVENUE ANALYSIS

24.1.11.3. GEOGRAPHIC PRESENCE

24.1.11.4. PRODUCT PORTFOLIO

24.1.11.5. RECENT DEVELOPMENTS

 

24.1.12 INTEGRA LIFESCIENCES CORPORATION

24.1.12.1. COMPANY OVERVIEW

24.1.12.2. REVENUE ANALYSIS

24.1.12.3. GEOGRAPHIC PRESENCE

24.1.12.4. PRODUCT PORTFOLIO

24.1.12.5. RECENT DEVELOPMENTS

24.1.13 BIORETEC GMBH

24.1.13.1. COMPANY OVERVIEW

24.1.13.2. REVENUE ANALYSIS

24.1.13.3. GEOGRAPHIC PRESENCE

24.1.13.4. PRODUCT PORTFOLIO

24.1.13.5. RECENT DEVELOPMENTS

24.1.14 ORTHOFIX MEDICAL INC.

24.1.14.1. COMPANY OVERVIEW

24.1.14.2. REVENUE ANALYSIS

24.1.14.3. GEOGRAPHIC PRESENCE

24.1.14.4. PRODUCT PORTFOLIO

24.1.14.5. RECENT DEVELOPMENTS

24.2 LOCAL COMPANIES

24.2.1 RENISHAW PLC.

24.2.1.1. COMPANY OVERVIEW

24.2.1.2. REVENUE ANALYSIS

24.2.1.3. GEOGRAPHIC PRESENCE

24.2.1.4. PRODUCT PORTFOLIO

24.2.1.5. RECENT DEVELOPMENTS

24.2.2 TST

24.2.2.1. COMPANY OVERVIEW

24.2.2.2. REVENUE ANALYSIS

24.2.2.3. GEOGRAPHIC PRESENCE

24.2.2.4. PRODUCT PORTFOLIO

24.2.2.5. RECENT DEVELOPMENTS

24.2.3 SURGIPHARM LIMITED

24.2.3.1. COMPANY OVERVIEW

24.2.3.2. REVENUE ANALYSIS

24.2.3.3. GEOGRAPHIC PRESENCE

24.2.3.4. PRODUCT PORTFOLIO

24.2.3.5. RECENT DEVELOPMENTS

 

24.2.4 BAIRDMED

24.2.4.1. COMPANY OVERVIEW

24.2.4.2. REVENUE ANALYSIS

24.2.4.3. GEOGRAPHIC PRESENCE

24.2.4.4. PRODUCT PORTFOLIO

24.2.4.5. RECENT DEVELOPMENTS

24.2.5 ORTHO-SOL DEVELOPMENT (PTY) LTD

24.2.5.1. COMPANY OVERVIEW

24.2.5.2. REVENUE ANALYSIS

24.2.5.3. GEOGRAPHIC PRESENCE

24.2.5.4. PRODUCT PORTFOLIO

24.2.5.5. RECENT DEVELOPMENTS

25 REPORTS

26 CONCLUSION

27 QUESTIONNAIRE

28 ABOUT DATA BRIDGE MARKET RESEARCH

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

The trauma devices market value was USD 13.66 billion in 2022.
The trauma devices market is projected to grow at a CAGR of 8.50% during the forecast period of 2023-2030.
The Middle East and Africa Trauma Devices Market is segmented by Product, Surgical Site, Tissue Type, Material Type, Patient Age, End User, and Distribution Channel.
Saudi Arabia dominates the Middle East and Africa trauma devices market due to the large number of companies, R&D capabilities, and growing adoption of minimally invasive surgical procedures.

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future